Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2012 Jan 27;68(Pt 2):240–243. doi: 10.1107/S1744309111041091

Expression, purification, crystallization and preliminary X-ray diffraction analysis of a ribokinase from the thermohalophile Halothermothrix orenii

Lokesh D Kori a, Andreas Hofmann b,c, Bharat K C Patel a,*
PMCID: PMC3274413  PMID: 22298009

A ribokinase gene (rbk) from the anaerobic halothermophilic bacterium Halothermothrix orenii was cloned and overexpressed in Escherichia coli. The recombinant protein (Ho-Rbk) was purified using immobilized metal-ion affinity chromatography and crystals were obtained using the sitting-drop method.

Keywords: ribokinases, sugar kinases, halothermophiles, Halothermothrix orenii

Abstract

A ribokinase gene (rbk) from the anaerobic halothermophilic bacterium Halothermothrix orenii was cloned and overexpressed in Escherichia coli. The recombinant protein (Ho-Rbk) was purified using immobilized metal-ion affinity chromatography and crystals were obtained using the sitting-drop method. Diffraction data were collected to a resolution of 3.1 Å using synchrotron radiation. The crystals belonged to the orthorhombic space group P212121, with unit-cell parameters a = 45.6, b = 61.1, c = 220.2, and contained two molecules per asymmetric unit. A molecular-replacement solution has been found and attempts are currently under way to build a model of the ribokinase. Efforts to improve crystal quality so that higher resolution data can be obtained are also being considered.

1. Introduction

Halothermothrix orenii is a heterotrophic, halophilic and thermophilic bacterium which grows optimally at 333 K with 5–10% NaCl at pH 6.5–7.0 (Cayol et al., 1994 ▶). The bacterium was isolated from the sediment of a Tunisian hypersaline lake, a habitat which is subject to seasonal changes in temperature and salinity. Sequencing of the genome of H. orenii identified a large battery of intracellular and extracellular glycosyl hydrolases and kinases (Mijts & Patel, 2001 ▶; Mavromatis et al., 2009 ▶). In an attempt to understand the adaptation of proteins from H. orenii to simultaneous exposure to high temperature and salts, its response to the fluctuating environmental conditions and the potential application of its enzymes in biotechnology, we initiated studies of the biochemistry and three-dimensional structures of amylase A (amyA), amylase B (amyB), sucrose phosphate synthase (SPS), fructokinase (FRK), β-glucosidase (BglA) (Li et al., 2002 ▶; Tan et al., 2003 ▶, 2008 ▶; Huynh et al., 2005 ▶; Sivakumar et al., 2006 ▶; Chua et al., 2008 ▶, 2010 ▶; Kori et al., 2011 ▶), β-glucosidase (Kori et al., unpublished work) and α-l-arabinofuranosidase (Kori & Patel, unpublished work) from H. orenii. As part of these ongoing investigations, we have cloned and expressed a ribokinase, a member of the PfkB-family carbohydrate kinases, from H. orenii. Other mem­bers of the PfkB family include fructokinase, 1-phosphofructokinase, 6-phosphofructokinase, hexokinase, ketohexokinase, adenosine kinase, ribo­kinase and 2-dehydro-3-deoxygluconokinase (Sigrell et al., 1997 ▶).

Ribokinase is involved in ribose phosphorylation and catalyses the following reaction in the presence of magnesium: ATP + d-ribose → ADP + d-ribose 5-phosphate. The substrate ribose, a monosaccharide, is the most abundant sugar in the environment and is metabolized by almost every living organism. d-Ribose is used in the synthesis of nucleotides and amino acids (histidine and tryptophan) and is also an important source of energy. To date, sugar phosphorylation is not completely understood and therefore the mechanism of sugar phosphorylation by ribokinase is a worthwhile target to explore. The core domain of ribokinase is an α/β-fold which harbours the catalytic site. A protruding four-stranded β-sheet with distinct topology forms a lid covering the active site where the enzymatic reaction takes place (Chua et al., 2010 ▶). Previously determined structures of Escherichia coli ribokinase show that d-ribose is enclosed in the substrate-binding site under the protruding β-sheet, and an induced-fit mechanism which enables the recognition and binding of the donor trinucleotide ATP as a co-substrate has been proposed (Sigrell et al., 1998 ▶, 1999 ▶).

2. Materials and methods

2.1. Expression and purification of recombinant ribokinase

A 918 bp ribokinase gene (GenBank accession No. YP_002508722) was PCR-amplified from the genomic DNA of H. orenii using MangoTaq DNA polymerase (Bioline, Australia) with an upstream primer 5′-TTCCATATGATGGGAAAAAGATAATTATG-3′ (NdeI restriction-enzyme site shown in bold) and a downstream primer 5′-TACTCGAGTCAATGATGGTGATGGTGATGCTTTTATCCGGACTCTTTC-3′ (XhoI restriction-enzyme site shown in bold and the oligonucleotide encoding the hexahistidine tag shown in italics). The PCR conditions used for DNA amplification have been described previously (Kori et al., 2011 ▶). The amplified product was purified using a QIAquick gel-extraction kit (Qiagen, Germany) and digested with NdeI and XhoI. The fragment was ligated with the plasmid vector pET22b(+) (Novagen) and transformed into E. coli DH5α (Bioline, Australia) using procedures described by Sambrook et al. (1989 ▶). After overnight incubation at 310 K, white colonies that developed on MacConkey ampicillin (100 µg ml−1) agar plates were selected and the presence of inserts was confirmed by colony PCR using T7 promoter (5′-TAATACGACTCACTATAGGG-3′) and T7 terminator (5′-GCTAGTTATTGCTCAGCGG-3′) primers and NdeI and XhoI restriction-enzyme digestion analysis. Plasmids that were confirmed as positive were used to transform E. coli BL21 (DE3) competent cells (Novagen) according to the manufacturer’s instructions and were screened for expression of ribokinase using previously described methods (Kori et al., 2011 ▶). A colony that overexpressed the recombinant ribokinase (designated Ho-Rbk) was used for further studies.

For overexpression of Ho-Rbk, the clone was inoculated into Luria Broth (LB) supplemented with 100 µg ml−1 ampicillin and grown to an OD650 of 0.6 at 310 K, at which stage IPTG was added to a final concentration of 3 mM and the culture was incubated for a further 6 h. The cells were harvested by centrifugation at 8000g for 10 min and resuspended in 5 ml 100 mM HEPES pH 7.0, 2 mg ml−1 lysozyme, 2 U ml−1 DNase I per gram of cells. The suspension was incubated for 45 min at 310 K and sonicated on ice. The cell lysate was clarified by centrifugation at 18 000g for 30 min at 278 K and the host proteins in the supernatant were denatured by incubation at 323 K for 45 min. The resulting precipitate was removed by centrifugation (18 000g for 30 min at 278 K) and the supernatant was filtered through a low-­protein-binding PVDF filter (Millipore, USA) to remove any remaining particulate material. The filtrate was loaded onto an NiSO4-charged Fractogel resin column (Merck) and incubated for 1 h at 278 K with gentle rotation on a tube rotator. The column was then washed with an equilibration buffer consisting of 500 mM NaCl, 20 mM Tris pH 8.0, washed with equilibration buffer containing a step gradient of 8, 15, 50, 75 and 100 mM imidazole and Ho-Rbk was eluted with 350 mM imidazole. The eluate was applied onto a U-Tube concentrator (30 kDa cutoff; Novagen), centrifuged at 10 000g for 8 min at 298 K and desalted with 100 mM NaCl, 20 mM HEPES pH 7.2. The final concentration of the recombinant protein was 9 mg ml−1 as determined by the Bradford assay (Bradford, 1976 ▶).

2.2. Crystallization

Screening of crystallization conditions was carried out at 289 K in 96-well MRC sitting-drop crystallization plates (Molecular Dimensions Ltd, Suffolk, England) using our large in-house factorial collection (1056 pre-formulated conditions). 1 µl recombinant Ho-Rbk (9 mg ml−1) was mixed with 1 µl reservoir solution and equilibrated against 100 µl reservoir solution.

2.3. Data collection and analysis

Crystals that developed over up to 10 d were mounted in nylon loops and cryoprotected with a 1:1(v:v) mixture of Paratone-N (Hampton Research, USA) and mineral oil (Oxoid, Australia) (Hope, 1988 ▶; Kori et al., 2011 ▶). X-ray diffraction experiments were carried out at the in-house diffractometer (Rigaku MicroMax-007 HF with VariMax optics and an R-AXIS IV++ detector) as well as on Australian Synchrotron beamline MX2. Data sets were indexed with MOSFLM (Leslie, 1992 ▶) and further processed with SCALA and TRUNCATE, which are part of the CCP4 program suite (Winn et al., 2011 ▶). Self-rotation functions were calculated with GLRF (Tong & Rossmann, 1990 ▶) and molecular-replacement calculations were carried out using Phaser/PHENIX (Adams et al., 2010 ▶).

3. Results and discussion

The rbk gene of H. orenii was successfully cloned and overexpressed in E. coli BL21 (DE3) cells and the protein was purified using an NiSO4-charged Fractogel resin column (Merck). Fig. 1 ▶ shows the protein profile of fractions collected during the purification process with imidazole.

Figure 1.

Figure 1

Ni2+-affinity chromatography purification of Ho-RbK. Fractions were collected and separated on a 4–12% Bis-Tris NuPAGE gel and the gel was stained with SimplyBlue Safe Stain (Invitrogen, USA). Lane M, molecular-weight markers (labelled in kDa); lane 1, cell lysate; lane 2, column flowthrough; lanes 3–8, imidazole wash (8, 15, 50, 75, 100 and 350 mM); lane 9, concentrated and desalted Ho-Rbk from 350 mM imidazole eluted fraction.

Out of 1056 tested factorial conditions, crystals were obtained in 181 different conditions. Only crystals obtained from one condition [20%(w/v) PEG 4000, 0.02 M Tris pH 9.0] after about 6 d showed X-­ray diffraction. The rectangular plate-like crystals had dimensions of 0.5 × 0.1 mm (Fig. 2 ▶) and diffracted to 3.1 Å resolution (Fig. 3 ▶). The unit-cell parameters of the orthorhombic crystals were a = 45.6, b = 61.0, c = 220.2 Å. Data-collection statistics are given in Table 1 ▶.

Figure 2.

Figure 2

Rectangular-shaped crystals of H. orenii ribokinase with typical dimensions of 0.5 × 0.1 mm. The black bar indicates 0.5 mm.

Figure 3.

Figure 3

X-ray diffraction pattern from the best diffracting crystal of Ho-Rbk acquired at the Australian Synchrotron beamline MX2. The image shows a complete 1° oscillation frame. The resolutions of the magenta rings are given in Å.

Table 1. Data-collection statistics.

Values in parentheses are for the highest resolution shell.

X-ray source Australian Synchrotron beamline MX2
Detector ADSC Quantum
Wavelength (Å) 0.95375
Temperature (K) 100
Crystal-to-detector distance (mm) 250
Rotation per image (°) 1
Total rotation (°) 180
Exposure time (s) 2
No. of crystals 1
Space group P212121
Unit-cell parameters (Å) a = 45.6, b = 61.1, c = 220.2
Resolution range (Å) 59–3.1 (3.27–3.10)
Wilson B factor (Å2) 57.2
Mosaicity (°) 0.52
Total No. of measurements 57751 (7084)
No. of unique reflections 11229 (1440)
〈I/σ(I)〉 5.3 (3.1)
Multiplicity 5.1 (4.9)
Completeness (%) 94.8 (85.1)
Rmerge 0.108 (0.238)

Serial extinctions were clearly visible in all three directions, resulting in the final assignment of P212121 as the space group. The Matthews coefficient (Matthews, 1968 ▶) indicated that there were two molecules in the asymmetric unit (see Table 2 ▶). In the self-rotation function calculated for ω = 180° no noncrystallographic peaks were observed. Therefore, the asymmetric unit may contain two molecules that are not related by a rotational symmetry axis. Alternatively, the asymmetric unit may consist of a P2-symmetric dimer that is oriented parallel to one of the crystallographic twofold axes ([100], [010], [001]).

Table 2. Calculation of Matthews coefficients for different numbers of molecules per asymmetric unit indicates the presence of a noncrystallographic dimer.

No. of molecules in asymmetric unit Matthews coefficient (Å3 Da−1) Solvent content (%)
1 4.3 71.2
2 2.1 42.4
3 1.4 13.6

Using PSIPRED (Bryson et al., 2005 ▶), mannose-binding protein from Rattus rattus (PDB entry 1rdk; Ng et al., 1996 ▶) was identified as the protein of known structure with highest homology to Ho-Rbk. Molecular-replacement calculations with various models based on 1rdk were conducted. The best solution was obtained with a poly-Ala model of 1rdk that had the protruding four-stranded β-sheet truncated. This solution suggested the presence of two Ho-Rbk monomers in the asymmetric unit which are not related by a rotational symmetry axis.

Current efforts to improve crystallization conditions in order to obtain better quality crystals of the apo and ligand-bound enzyme are under way. We are also attempting to build a model of Ho-Rbk using the available molecular-replacement solution.

Acknowledgments

This work is part of a PhD program (LK). LK is the recipient of Griffith University Postgraduate Research Scholarship (GUPRS) and Griffith University International Postgraduate Research Scholarship (GUIPRS) awards, Australia. AH gratefully acknowledges the support of the Australian Synchrotron in the form of beam time.

References

  1. Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.
  2. Bradford, M. M. (1976). Anal. Biochem. 72, 248–254. [DOI] [PubMed]
  3. Bryson, K., McGuffin, L. J., Marsden, R. L., Ward, J. J., Sodhi, J. S. & Jones, D. T. (2005). Nucleic Acids Res. 33, W36–W38. [DOI] [PMC free article] [PubMed]
  4. Cayol, J.-L., Ollivier, B., Patel, B. K. C., Prensier, G., Guezennec, J. & Garcia, J.-L. (1994). Int. J. Syst. Bacteriol. 44, 534–540. [DOI] [PubMed]
  5. Chua, T. K., Bujnicki, J. M., Tan, T.-C., Huynh, F., Patel, B. K. & Sivaraman, J. (2008). Plant Cell, 20, 1059–1072. [DOI] [PMC free article] [PubMed]
  6. Chua, T. K., Seetharaman, J., Kasprzak, J. M., Ng, C., Patel, B. K., Love, C., Bujnicki, J. M. & Sivaraman, J. (2010). J. Struct. Biol. 171, 397–401. [DOI] [PubMed]
  7. Hope, H. (1988). Acta Cryst. B44, 22–26. [DOI] [PubMed]
  8. Huynh, F., Tan, T.-C., Swaminathan, K. & Patel, B. K. C. (2005). Acta Cryst. F61, 116–117. [DOI] [PMC free article] [PubMed]
  9. Kori, L. D., Hofmann, A. & Patel, B. K. C. (2011). Acta Cryst. F67, 111–113. [DOI] [PMC free article] [PubMed]
  10. Leslie, A. G. W. (1992). Jnt CCP4/ESF–EACBM Newsl. Protein Crystallogr. 26
  11. Li, N., Patel, B. K. C., Mijts, B. N. & Swaminathan, K. (2002). Acta Cryst. D58, 2125–2126. [DOI] [PubMed]
  12. Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
  13. Mavromatis, K., Ivanova, N., Anderson, I., Lykidis, A., Hooper, S. D., Sun, H., Kunin, V., Lapidus, A., Hugenholtz, P., Patel, B. & Kyrpides, N. C. (2009). PLoS One, 4, e4192. [DOI] [PMC free article] [PubMed]
  14. Mijts, B. N. & Patel, B. K. C. (2001). Extremophiles, 5, 61–69. [DOI] [PubMed]
  15. Ng, K. K.-S., Drickamer, K. & Weis, W. I. (1996). J. Biol. Chem. 271, 663–674. [DOI] [PubMed]
  16. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory Press.
  17. Sigrell, J. A., Cameron, A. D., Jones, T. A. & Mowbray, S. L. (1997). Protein Sci. 6, 2474–2476. [DOI] [PMC free article] [PubMed]
  18. Sigrell, J. A., Cameron, A. D., Jones, T. A. & Mowbray, S. L. (1998). Structure, 6, 183–193. [DOI] [PubMed]
  19. Sigrell, J. A., Cameron, A. D. & Mowbray, S. L. (1999). J. Mol. Biol. 290, 1009–1018. [DOI] [PubMed]
  20. Sivakumar, N., Li, N., Tang, J. W., Patel, B. K. & Swaminathan, K. (2006). FEBS Lett. 580, 2646–2652. [DOI] [PubMed]
  21. Tan, T.-C., Mijts, B. N., Swaminathan, K., Patel, B. K. C. & Divne, C. (2008). J. Mol. Biol. 378, 852–870. [DOI] [PubMed]
  22. Tan, T. C., Yien, Y. Y., Patel, B. K. C., Mijts, B. N. & Swaminathan, K. (2003). Acta Cryst. D59, 2257–2258. [DOI] [PubMed]
  23. Tong, L. & Rossmann, M. G. (1990). Acta Cryst. A46, 783–792. [DOI] [PubMed]
  24. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES